Determinants of 1-year survival in critically ill acute leukemia patients: a GRRR-OH study

References

• Schellongowski P, Staudinger T, Kundi M, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica. 2011;96:231–237.
   PubMed Web of Science ®Google Scholar
• Halpern AB, Culakova E, Walter RB, et al. Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit. JAMA Oncol. 2017;3:374–381.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Mokart D, Pene F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium–a groupe de recherche respiratoire en reanimation onco-hematologique study (a respiratory research group in oncology-hematological resuscitation study). J Clin Oncol. 2013;31:2810–2818. French.
   PubMed Web of Science ®Google Scholar
• Kraguljac AP, Croucher D, Christian M, et al. Outcomes and predictors of mortality for patients with acute leukemia admitted to the intensive care unit. Can Respir J. 2016;2016:3027656.
   PubMed Web of Science ®Google Scholar
• Rabbat A, Chaoui D, Montani D, et al. Prognosis of patients with acute myeloid leukaemia admitted to intensive care. Br J Haematol. 2005;129:350–357.
   PubMed Web of Science ®Google Scholar
• Pohlen M, Thoennissen NH, Braess J, et al. Patients with acute myeloid leukemia admitted to intensive care units: outcome analysis and risk prediction. PLoS One. 2016;11:e0160871.
   PubMed Web of Science ®Google Scholar
• Faucher E, Cour M, Jahandiez V, et al. Short- and long-term outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis. Oncotarget. 2016;7:22427–22438.
   PubMed Web of Science ®Google Scholar
• Jackson K, Mollee P, Morris K, et al. Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. Leuk Lymphoma. 2014;55:97–104.
   PubMed Web of Science ®Google Scholar
• Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051–1062.
   PubMed Web of Science ®Google Scholar
• Hayani O, Al-Beihany A, Zarychanski R, et al. Impact of critical care outreach on hematopoietic stem cell transplant recipients: a cohort study. Bone Marrow Transplant. 2011;46:1138–1144.
   PubMed Web of Science ®Google Scholar
• Bokhari SW, Munir T, Memon S, et al. Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission. Ann Hematol. 2010;89:505–512.
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453–474.
   PubMed Web of Science ®Google Scholar
• Keenan T, LeBlanc TW, Traeger L, et al. Outcomes for older patients with acute myeloid leukemia admitted to the intensive care unit. Blood. 2015;126:531.
   PubMedGoogle Scholar
• Lamia B, Hellot MF, Girault C, et al. Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU. Intensive Care Med. 2006;32:1560–1568.
   PubMed Web of Science ®Google Scholar
• Merz TM, Schar P, Buhlmann M, et al. Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study. Crit Care. 2008;12:R75.
   PubMed Web of Science ®Google Scholar
• Bernal T, Pardavila EV, Bonastre J, et al. Survival of hematological patients after discharge from the intensive care unit: a prospective observational study. Crit Care. 2013;17:R302.
   PubMed Web of Science ®Google Scholar
• Yeo CD, Kim JW, Kim SC, et al. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care. 2012;27:739.e1–736.e6.
   Web of Science ®Google Scholar
• Geerse DA, Span LF, Pinto-Sietsma SJ, et al. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Case Rep Intern Med. 2011;22:57–61.
   Google Scholar
• Sippel C, Kim Y, Wallau A, et al. AML versus ICU: outcome of septic AML patients in an intensive care setting. J Cancer Res Clin Oncol. 2015;141:1645–1651.
   PubMed Web of Science ®Google Scholar
• Oriol A, Vives S, Hernandez-Rivas JM, et al. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica. 2010;95:589–596.
   PubMed Web of Science ®Google Scholar
• Schlenk RF, Dohner K, Mack S, et al. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J Clin Oncol. 2010;28:4642–4648.
   PubMed Web of Science ®Google Scholar
• Duval M, Klein JP, He W, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28:3730–3738.
   PubMed Web of Science ®Google Scholar
• Rowe JM, Kim HT, Cassileth PA, et al. Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group. Cancer. 2010;116:5012–5021.
   PubMed Web of Science ®Google Scholar
• Ostgard LS, Kjeldsen E, Holm MS, et al. Reasons for treating secondary AML as de novo AML. Eur J Haematol. 2010;85:217–226.
   PubMed Web of Science ®Google Scholar
• Giri S, Chi M, Johnson B, et al. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis. Leuk Res. 2015;39:1342–1346.
   PubMed Web of Science ®Google Scholar
• Hulegardh E, Nilsson C, Lazarevic V, et al. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry. Am J Hematol. 2015;90:208–214.
   PubMed Web of Science ®Google Scholar
• Amrein PC, Stone RM, Ballen KK, et al. Outcomes for older patients with acute myeloid leukemia admitted to the intensive care unit. Blood. 2015;126:2104.
   Google Scholar
• Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children’s Leukaemia Working Parties. Blood. 1998;92:2322–2333.
   PubMed Web of Science ®Google Scholar
• Cornelissen JJ, Breems D, van Putten WL, et al. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. J Clin Oncol. 2012;30:2140–2146.
   PubMed Web of Science ®Google Scholar
• Byrd JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100:4325–4336.
   PubMed Web of Science ®Google Scholar
• van Gelder M, de Wreede LC, Schetelig J, et al. Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia. Leukemia. 2013;27:879–888.
   PubMed Web of Science ®Google Scholar
• Thakkar SG, Fu AZ, Sweetenham JW, et al. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer. 2008;112:2233–2240.
   PubMed Web of Science ®Google Scholar
• Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–447.
   PubMed Web of Science ®Google Scholar
• Azoulay E, Metnitz B, Sprung CL, et al. End-of-life practices in 282 intensive care units: data from the SAPS 3 database. Intensive Care Med. 2009;35:623–630.
   PubMed Web of Science ®Google Scholar
• Nguyen YL, Wallace DJ, Yordanov Y, et al. The volume-outcome relationship in critical care: a systematic review and meta-analysis. Chest. 2015;148:79–92.
   PubMed Web of Science ®Google Scholar